Application of a Positive Psychology Program for the Development of Emotional Skills in Prison

October 22, 2021 updated by: University Hospital, Montpellier

Application of a Positive Psychology Program for the Development of Emotional Skills in Prison : Feasibility Study

Studies show that emotional competence plays a significant role in psychological and physical health, and that programs aimed at their development are effective. Can a positive psychology program aimed at the development of emotional competence be implemented as part of care in lieu of deprivation of liberty? The investigators hypothesize the interest and possibility of implementing an emotional skills development program in the specific context of custodial care.

The main expected outcome of this study is the identification of necessary adaptations of the emotional skills development program of Kotsou, I. et al (2011) for its implementation in remand homes.

Study Overview

Status

Completed

Detailed Description

The expected secondary outcome is the identification of the interest of emotional skills development program (in prison) regarding :

  • Therapeutic support for patients meeting the criteria for borderline personality disorder
  • Participant satisfaction
  • The development of emotional skills

Study Type

Observational

Enrollment (Actual)

12

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • Uhmontpellier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Major patients followed up at the Health Unit of the Villeneuve-lès-Maguelone Remand Prison

Description

Inclusion criteria:

  • Meet the criteria for borderline personality disorder (DSM-V),
  • Interest in the issue of emotional skills development,
  • Comprehension and use of the French language adapted to the study,
  • Disposition to group practice,
  • Attentive disposition allowing to participate in a therapeutic activity for 3 hours.
  • Psychological/psychiatrical follow-up at the Health Unit of the Villeneuve-lès-Maguelone prison

Exclusion criteria:

  • Minor patients
  • Releasable before July 2021,
  • Decompensated psychiatric disorders,
  • Patient in withdrawal syndrome.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Control group
Control group : Major borderline patients followed up at the Health Unit of the Villeneuve-lès-Maguelone Remand Prison
Test group
Test group : Major borderline patients followed up at the Health Unit of the Villeneuve-lès-Maguelone Remand Prison
Emotional Skills Development Program (positive psychology)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
rate of vompliance with the number of sessions
Time Frame: 1 day
Achievement of the program's implementation and participation objectives : compliance with the number of sessions
1 day
Rate of respect of the frequency of sessions
Time Frame: 1 day
Achievement of the program's implementation and participation objectives : respect of the frequency of sessions: weekly
1 day
rate of respect of the duration of each session
Time Frame: 1 day
Achievement of the program's implementation and participation objectives : respect of the duration of each session
1 day
rate of respect of the minimum number of participants
Time Frame: 1 day
Achievement of the program's implementation and participation objectives : respect of the minimum number of participants
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respect of the duration of the theoretical/practical reminders
Time Frame: 1 day
Achievement of the program's implementation and participation objectives : Respect of the duration of the theoretical/practical reminders
1 day
respect of the frequency of theoretical/practical remote reminders
Time Frame: 1 day
Achievement of the program's implementation and participation objectives : respect of the frequency of theoretical/practical remote reminders
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Magali RUBIO, Psychologist, University Hospital, Montpellier

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2021

Primary Completion (Actual)

May 30, 2021

Study Completion (Actual)

June 1, 2021

Study Registration Dates

First Submitted

January 29, 2021

First Submitted That Met QC Criteria

February 5, 2021

First Posted (Actual)

February 9, 2021

Study Record Updates

Last Update Posted (Actual)

October 25, 2021

Last Update Submitted That Met QC Criteria

October 22, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • RECHMPL21_0017

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

NC

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Borderline Personality Disorder

Clinical Trials on Emotional Skills Development Program

3
Subscribe